This clearly showed that PD-1+ cells have a higher cytotoxic capacity compared to PD-1− cells in both CLL patients and controls (Supplementary Fig. 2A–F) confirming that PD-1-expressing CD4+ T cells have cytotoxic capacity, also in CLL. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.